AMSTERDAM, Feb 26 (Reuters) - Dutch chemical group Akzo Nobel NV (AKZO.AS: Quote, Profile , Research) said on Monday it plans to list its pharmaceutical unit Organon before the end of March and hopes to get U.S. regulatory approval for a key drug by 2008.
